Company registration number 04677336 (England and Wales)
WESSEX CARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2025
31 March 2025
WESSEX CARE LIMITED
COMPANY INFORMATION
Directors
Mr M Airey
Mrs PM Airey
Mr C Airey
Mrs JR Airey
Company number
04677336
Registered office
7 Bournemouth Road
Chandler's Ford
Eastleigh
Hampshire
SO53 3DA
Auditor
Knight Goodhead Limited
7 Bournemouth Road
Chandler's Ford
Eastleigh
Hampshire
SO53 3DA
WESSEX CARE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 8
Profit and loss account
9
Group and company balance sheets
10 - 11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Company statement of cash flows
15
Notes to the financial statements
16 - 33
WESSEX CARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025
1
The directors present the strategic report for the year ended 31 March 2025.
Review of the business
The year ended 31 March 2025 has been another successful year for Wessex Care Limited, with the company continuing to deliver high-quality care while maintaining stable financial performance. Alongside established local authority placements, the business has seen a gradual increase in private referrals, supporting a more balanced referral profile.
Principal risks and uncertainties
The principal ongoing risk to the business remains the maintenance of occupancy levels across the company’s homes, particularly as additional care provision becomes available within the local area. Maintaining high standards of care and the quality of the physical environment remains central to sustaining strong occupancy levels.
Future uncertainties include the continuation and renewal of fixed-rate bed contracts with Wiltshire Council. While the company continues to work constructively with the Council, the evolving commissioning environment and cost pressures create an element of uncertainty. This risk is partially mitigated by the company’s growing proportion of private referrals and diversification of income streams.
Workforce availability and capability also remain key risks. While staffing levels across the business are currently stable, the sector continues to experience ongoing change and emerging challenges, including recruitment pressures, cost inflation and increasing regulatory expectations. Wessex Care Limited continues to invest in staff training, development and quality assurance processes, including the use of ‘Critical Friend’ inspections to support and monitor staffing standards across services.
Development and performance
During the year, Wessex Care Limited has continued to invest in the development of the business and its physical estate. The company is nearing completion of Castle View Care Centre, a newly built service designed to support individuals with complex needs, which represents a significant strategic investment for the group.
In addition, continuous development across existing Wessex Care sites has remained a priority. Planning is underway for the redevelopment of Milford Manor Care Centre, with works expected to commence in late 2025.
Total income increased by 4.5% to £10,209,548, reflecting sustained occupancy levels, an improving private referral mix and the quality of care delivered. Operating costs increased during the year, with direct costs rising by 5.7% to £5,808,475, primarily due to increases in staff pay rates and agency staffing costs. Administrative expenses increased by 1.6%, driven by general increases in rent, utilities, insurance and repair costs.
WESSEX CARE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
2
Key performance indicators
Wessex Care Limited uses key financial performance indicators to monitor underlying growth and profitability. Turnover increased by 4.5% during the year. Gross profit was 43.1% of turnover, compared to 43.7% in 2024.
Administrative expenses represented 28% of turnover (2024: 28.8%), while profit before taxation was 8.3% of turnover (2024: 8%).
Non-financial performance indicators include occupancy levels. During the year ended 31 March 2025, the lowest monthly financial occupancy was 91% (2024: 92%), while the highest monthly financial occupancy reached 99% (2024: 98%).
Other performance indicators
Wiltshire Council and the NHS Integrated Care Service continue to monitor Block and Framework contracts, including the company’s specialist Intensive Rehabilitation service. Performance against contractual requirements has remained strong throughout the year.
The company has continued to be subject to Care Quality Commission (CQC) oversight using its intelligence-led, risk-based profiling approach. Services have remained compliant with regulatory requirements and continue to meet expected standards of care and governance.
Mr C Airey
Director
30 December 2025
WESSEX CARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
3
The directors present their annual report and financial statements for the year ended 31 March 2025.
Principal activities
The principal activity of the company and group continued to be that of running residential care homes and property improvement to the houses.
Results and dividends
The results for the year are set out on page 9.
Ordinary dividends were paid amounting to £312,744 (2024: £357,744).
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr M Airey
Mrs PM Airey
Mr C Airey
Mrs JR Airey
Auditor
In accordance with the company's articles, a resolution proposing that Knight Goodhead Limited be reappointed as auditor of the group will be put at a General Meeting.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
On behalf of the board
Mr C Airey
Director
30 December 2025
WESSEX CARE LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025
4
The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
WESSEX CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WESSEX CARE LIMITED
5
Opinion
We have audited the financial statements of Wessex Care Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2025 which comprise the group profit and loss account, the group and company balance sheet, the group and company statement of changes in equity, the group and company statement of cash flows, and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2025 and of the group's profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
WESSEX CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESSEX CARE LIMITED
6
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.
WESSEX CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESSEX CARE LIMITED
7
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud and considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.
The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations.
We identified the laws and regulations applicable to the company through discussions with directors and other management and we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence.
To address the risk of fraud through management bias and override of controls, we performed analytical procedures to identify any unusual or unexpected relationships, tested journal entries to identify unusual transactions and investigated the rationale behind significant or unusual transactions.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
agreeing financial statement disclosures to underlying supporting documentation;
reading the minutes of meetings of those charged with governance; and
enquiring of management as to actual and potential litigation and claims.
There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the trustees and other management and the inspection of regulatory and legal correspondence, if any.
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
WESSEX CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESSEX CARE LIMITED
8
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Knight Goodhead Limited is eligible for appointment as auditor of the company by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Christopher Goodhead FCA
(Senior Statutory Auditor)
For and on behalf of Knight Goodhead Limited
30 December 2025
Chartered Accountants
Statutory Auditor
7 Bournemouth Road
Chandler's Ford
Eastleigh
Hampshire
SO53 3DA
WESSEX CARE LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2025
9
2025
2024
Notes
£
£
Turnover
10,209,548
9,772,933
Cost of sales
(5,808,475)
(5,497,919)
Gross profit
4,401,073
4,275,014
Administrative expenses
(2,859,466)
(2,814,244)
Operating profit
2
1,541,607
1,460,770
Interest receivable and similar income
51,499
47,882
Interest payable and similar expenses
5
(747,700)
(726,567)
Profit before taxation
845,406
782,085
Tax on profit
6
(115,814)
(217,070)
Profit for the financial year
729,592
565,015
Profit for the financial year is all attributable to the owners of the parent company.
WESSEX CARE LIMITED
GROUP AND COMPANY BALANCE SHEETS
AS AT
31 MARCH 2025
31 March 2025
10
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
8
19,086,708
15,542,194
19,086,708
15,542,194
Investments
9
107
107
19,086,708
15,542,194
19,086,815
15,542,301
Current assets
Stocks
25,700
25,700
25,700
25,700
Debtors
10
1,436,097
1,325,813
1,506,598
1,344,391
Cash at bank and in hand
680,295
767,508
675,770
744,367
2,142,092
2,119,021
2,208,068
2,114,458
Creditors: amounts falling due within one year
11
(1,719,137)
(1,522,169)
(1,800,196)
(1,562,949)
Net current assets
422,955
596,852
407,872
551,509
Total assets less current liabilities
19,509,663
16,139,046
19,494,687
16,093,810
Creditors: amounts falling due after more than one year
12
(12,888,817)
(10,198,489)
(12,888,817)
(10,198,489)
Provisions for liabilities
Deferred tax liability
14
(1,164,999)
(901,558)
(1,164,999)
(901,558)
Net assets
5,455,847
5,038,999
5,440,871
4,993,763
Capital and reserves
Called up share capital
16
113
113
113
113
Share premium account
319,992
319,992
319,992
319,992
Capital redemption reserve
1
1
Profit and loss reserves
5,135,741
4,718,893
5,120,766
4,673,658
Total equity
5,455,847
5,038,999
5,440,871
4,993,763
WESSEX CARE LIMITED
GROUP AND COMPANY BALANCE SHEETS (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
11
The financial statements were approved by the board of directors and authorised for issue on 30 December 2025 and are signed on its behalf by:
30 December 2025
Mr M Airey
Director
Company registration number 04677336 (England and Wales)
WESSEX CARE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
12
Share capital
Share premium account
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 April 2023
113
319,992
1
4,511,622
4,831,728
Year ended 31 March 2024:
Profit and total comprehensive income
-
-
-
565,015
565,015
Dividends
7
-
-
-
(357,744)
(357,744)
Balance at 31 March 2024
113
319,992
1
4,718,893
5,038,999
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
-
729,592
729,592
Dividends
7
-
-
-
(312,744)
(312,744)
Balance at 31 March 2025
113
319,992
1
5,135,741
5,455,847
WESSEX CARE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
13
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2023
113
319,992
4,504,135
4,824,240
Year ended 31 March 2024:
Profit and total comprehensive income for the year
-
-
527,267
527,267
Dividends
7
-
-
(357,744)
(357,744)
Balance at 31 March 2024
113
319,992
4,673,658
4,993,763
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
759,852
759,852
Dividends
7
-
-
(312,744)
(312,744)
Balance at 31 March 2025
113
319,992
5,120,766
5,440,871
WESSEX CARE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2025
14
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
21
2,030,540
1,455,856
Interest paid
(747,700)
(726,567)
Income taxes paid
(139,322)
(4,982)
Net cash inflow from operating activities
1,143,518
724,307
Investing activities
Purchase of tangible fixed assets
(3,735,245)
(1,970,034)
Interest received
51,499
47,882
Net cash used in investing activities
(3,683,746)
(1,922,152)
Financing activities
Proceeds from new bank loans
2,962,344
1,697,836
Repayment of bank loans
(192,013)
(175,765)
Payment of finance leases obligations
(4,572)
(5,575)
Dividends paid to equity shareholders
(312,744)
(357,744)
Net cash generated from financing activities
2,453,015
1,158,752
Net decrease in cash and cash equivalents
(87,213)
(39,093)
Cash and cash equivalents at beginning of year
767,508
806,601
Cash and cash equivalents at end of year
680,295
767,508
WESSEX CARE LIMITED
COMPANY STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2025
15
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
22
2,036,605
1,453,505
Interest paid
(747,693)
(726,567)
Income taxes paid
(126,778)
(4,982)
Net cash inflow from operating activities
1,162,134
721,956
Investing activities
Purchase of tangible fixed assets
(3,735,245)
(1,970,034)
Interest received
51,499
47,882
Net cash used in investing activities
(3,683,746)
(1,922,152)
Financing activities
Proceeds from new bank loans
2,962,344
1,697,836
Repayment of bank loans
(192,013)
(175,765)
Payment of finance leases obligations
(4,572)
(5,575)
Dividends paid to equity shareholders
(312,744)
(357,744)
Net cash generated from financing activities
2,453,015
1,158,752
Net decrease in cash and cash equivalents
(68,597)
(41,444)
Cash and cash equivalents at beginning of year
744,367
785,811
Cash and cash equivalents at end of year
675,770
744,367
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
16
1
Accounting policies
Company information
Wessex Care Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is 7 Bournemouth Road, Chandler's Ford, Eastleigh, Hampshire, SO53 3DA.
The group consists of Wessex Care Limited and all of its subsidiaries.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
1.2
Business combinations
In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.
Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies (Continued)
17
1.3
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Wessex Care Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.
All financial statements are made up to 31 March 2025. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
1.4
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.5
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
£nil
Leasehold improvements
15 years straight line
Fixtures and fittings
25% straight line
Motor vehicles
25% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies (Continued)
18
1.7
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.8
Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
1.9
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.10
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies (Continued)
19
1.11
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies (Continued)
20
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
1.12
Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
1.13
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies (Continued)
21
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.15
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.16
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
22
2
Operating profit
2025
2024
£
£
Operating profit for the year is stated after charging:
Fees payable to the group's auditor for the audit of the group's financial statements
18,000
17,250
Depreciation of owned tangible fixed assets
190,731
236,333
3
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2025
2024
2025
2024
Number
Number
Number
Number
Management
12
11
10
9
Admin
4
4
4
4
Carers
85
89
85
89
Nursing
9
19
9
19
Welfare
4
3
4
3
RGN
17
8
17
8
Principal Healthcare Assistant
4
3
4
3
Kitchen staff
10
12
10
12
Community services
5
7
5
7
Maintenance & domestics
25
24
25
24
Total
175
180
173
178
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
3
Employees (Continued)
23
Their aggregate remuneration comprised:
Group
Company
2025
2024
2025
2024
£
£
£
£
Wages and salaries
4,946,030
4,637,607
4,946,030
4,637,607
Social security costs
463,145
419,363
463,145
419,363
Pension costs
88,132
86,918
88,132
86,918
5,497,307
5,143,888
5,497,307
5,143,888
4
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
17,256
17,256
5
Interest payable and similar expenses
2025
2024
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
747,693
724,318
Other finance costs:
Interest on finance leases and hire purchase contracts
-
2,249
Other interest
7
-
Total finance costs
747,700
726,567
6
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
142,537
Adjustments in respect of prior periods
(147,627)
Total current tax
(147,627)
142,537
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
6
Taxation
2025
2024
£
£ (Continued)
24
Deferred tax
Origination and reversal of timing differences
263,441
74,533
Total tax charge
115,814
217,070
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
845,406
782,085
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
211,352
195,521
Tax effect of expenses that are not deductible in determining taxable profit
3,367
6,924
Adjustments in respect of prior years
(137,540)
Depreciation add back
47,683
59,054
Capital allowances
(273,632)
(118,962)
Fixed asset timing differences movement
263,440
74,533
Loss in subsidiary available for relief
1,144
Taxation charge
115,814
217,070
7
Dividends
2025
2024
Recognised as distributions to equity holders:
£
£
Group
Final paid
-
5,833
Interim paid
312,744
357,744
312,744
363,577
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
7
Dividends (Continued)
25
Company
Final paid
-
-
Interim paid
312,744
357,744
312,744
357,744
8
Tangible fixed assets
Group
Freehold land and buildings
Leasehold improvements
Assets under construction
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 April 2024
12,318,725
1,328,922
2,370,632
1,052,707
117,753
17,188,739
Additions
3,601,392
133,853
3,735,245
Disposals
(5,171)
(58,500)
(63,671)
At 31 March 2025
12,318,725
1,328,922
5,972,024
1,181,389
59,253
20,860,313
Depreciation and impairment
At 1 April 2024
640,815
894,978
110,752
1,646,545
Depreciation charged in the year
75,151
111,106
4,474
190,731
Eliminated in respect of disposals
(5,171)
(58,500)
(63,671)
At 31 March 2025
715,966
1,000,913
56,726
1,773,605
Carrying amount
At 31 March 2025
12,318,725
612,956
5,972,024
180,476
2,527
19,086,708
At 31 March 2024
12,318,725
688,107
2,370,632
157,729
7,001
15,542,194
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
8
Tangible fixed assets (Continued)
26
Company
Freehold land and buildings
Leasehold improvements
Assets under construction
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 April 2024
12,318,725
1,328,922
2,370,632
1,047,536
117,753
17,183,568
Additions
3,601,392
133,853
3,735,245
Disposals
(58,500)
(58,500)
At 31 March 2025
12,318,725
1,328,922
5,972,024
1,181,389
59,253
20,860,313
Depreciation and impairment
At 1 April 2024
640,815
889,807
110,752
1,641,374
Depreciation charged in the year
75,151
111,106
4,474
190,731
Eliminated in respect of disposals
(58,500)
(58,500)
At 31 March 2025
715,966
1,000,913
56,726
1,773,605
Carrying amount
At 31 March 2025
12,318,725
612,956
5,972,024
180,476
2,527
19,086,708
At 31 March 2024
12,318,725
688,107
2,370,632
157,729
7,001
15,542,194
9
Fixed asset investments
Group
Company
2025
2024
2025
2024
£
£
£
£
Investments in subsidiaries
107
107
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
9
Fixed asset investments (Continued)
27
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 April 2024 and 31 March 2025
107
Carrying amount
At 31 March 2025
107
At 31 March 2024
107
10
Debtors
Group
Company
2025
2024
2025
2024
Amounts falling due within one year:
£
£
£
£
Trade debtors
133,218
182,055
15,638
Corporation tax recoverable
143,316
133,229
Amounts owed by group undertakings
-
-
114,136
72,009
Other debtors
(91,240)
(117,099)
16,224
21,719
Prepayments and accrued income
473,167
537,197
465,373
511,365
658,461
602,153
728,962
620,731
Amounts falling due after more than one year:
Other debtors
777,636
723,660
777,636
723,660
Total debtors
1,436,097
1,325,813
1,506,598
1,344,391
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
28
11
Creditors: amounts falling due within one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans
13
320,303
241,491
320,303
241,491
Obligations under finance leases
453
3,834
453
3,834
Trade creditors
544,883
307,465
372,249
370,117
Amounts owed to group undertakings
105
105
Corporation tax payable
143,633
131,089
Other taxation and social security
105,311
108,730
101,684
105,032
Other creditors
340,385
361,900
339,850
358,115
Accruals and deferred income
407,802
355,116
665,552
353,166
1,719,137
1,522,169
1,800,196
1,562,949
Obligations under finance leases are secured on the assets concerned.
12
Creditors: amounts falling due after more than one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans and overdrafts
13
12,888,817
10,197,298
12,888,817
10,197,298
Obligations under finance leases
1,191
1,191
12,888,817
10,198,489
12,888,817
10,198,489
Obligations under finance leases are secured on the assets concerned.
Amounts included above which fall due after five years are as follows:
Payable by instalments
11,450,639
8,135,424
11,450,639
8,135,424
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
29
13
Loans and overdrafts
Group
Company
2025
2024
2025
2024
£
£
£
£
Bank loans
13,209,120
10,438,789
13,209,120
10,438,789
Payable within one year
320,303
241,491
320,303
241,491
Payable after one year
12,888,817
10,197,298
12,888,817
10,197,298
The long-term loans are secured by fixed charges over the assets of the company.
14
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:
Liabilities
Liabilities
2025
2024
Group
£
£
Accelerated capital allowances
1,194,401
903,428
Tax losses
(27,747)
-
Retirement benefit obligations
(1,655)
(1,870)
1,164,999
901,558
Liabilities
Liabilities
2025
2024
Company
£
£
Accelerated capital allowances
1,194,401
903,428
Tax losses
(27,747)
-
Retirement benefit obligations
(1,655)
(1,870)
1,164,999
901,558
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
14
Deferred taxation (Continued)
30
Group
Company
2025
2025
Movements in the year:
£
£
Liability at 1 April 2024
901,558
901,558
Charge to profit or loss
263,441
263,441
Liability at 31 March 2025
1,164,999
1,164,999
15
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
88,132
86,918
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
16
Share capital
Group and company
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
108
108
108
108
A Ordinary shares of £1 each
1
1
1
1
B Ordinary shares of £1 each
1
1
1
1
C Ordinary shares of £1 each
1
1
1
1
D Ordinary shares of £1 each
1
1
1
1
E Ordinary shares of £1 each
1
1
1
1
113
113
113
113
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
31
17
Operating lease commitments
At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
Group
Company
2025
2024
2025
2024
£
£
£
£
Within one year
470,305
506,812
470,305
506,812
Between two and five years
1,636,664
1,585,297
1,636,664
1,585,297
In over five years
22,095
678,797
22,095
678,797
2,129,064
2,770,906
2,129,064
2,770,906
18
Related party transactions
During the year the company loaned Salisbury Taprooms Ltd £3,127 (2024: £327,705) and charged interest of £43,836 (2024: £41,359). The balance outstanding at the year end was £777,636 (2024: £730,673). The company holds a legal charge over the property owned by Salisbury Taprooms Ltd. Salisbury Taprooms Ltd is a company controlled by the directors of Wessex Care Ltd.
19
Directors' transactions
Dividends totalling £310,744 (2024 - £355,744) were paid in the year in respect of shares held by the company's directors.
During the year the company paid rent amounting to £360,000 (2024: £338,400) to the Airey SIBA. The beneficiaries of this fund are Mr M Airey and Mrs P Airey, directors and shareholders.
During the year the company paid rent amounting to £12,000 (2024: £12,000) to the Casa MP Ltd, a company controlled by the directors.
20
Controlling party
The company's controlling party is Mr M Airey and Mrs P Airey, directors, by virtue of their shareholdings.
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
32
21
Cash generated from group operations
2025
2024
£
£
Profit after taxation
729,592
565,015
Adjustments for:
Taxation charged
115,814
217,070
Finance costs
747,700
726,567
Investment income
(51,499)
(47,882)
Depreciation and impairment of tangible fixed assets
190,731
236,333
Movements in working capital:
Decrease/(increase) in debtors
33,032
(496,524)
Increase in creditors
265,170
255,277
Cash generated from operations
2,030,540
1,455,856
22
Cash generated from operations - company
2025
2024
£
£
Profit after taxation
759,852
527,267
Adjustments for:
Taxation charged
125,901
204,526
Finance costs
747,693
726,567
Investment income
(51,499)
(47,882)
Depreciation and impairment of tangible fixed assets
190,731
236,333
Movements in working capital:
Increase in debtors
(28,978)
(468,438)
Increase in creditors
292,905
275,132
Cash generated from operations
2,036,605
1,453,505
WESSEX CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
33
23
Analysis of changes in net debt - group
1 April 2024
Cash flows
31 March 2025
£
£
£
Cash at bank and in hand
767,508
(87,213)
680,295
Borrowings excluding overdrafts
(10,438,789)
(2,770,331)
(13,209,120)
Obligations under finance leases
(5,025)
4,572
(453)
(9,676,306)
(2,852,972)
(12,529,278)
24
Analysis of changes in net debt - company
1 April 2024
Cash flows
31 March 2025
£
£
£
Cash at bank and in hand
744,367
(68,597)
675,770
Borrowings excluding overdrafts
(10,438,789)
(2,770,331)
(13,209,120)
Obligations under finance leases
(5,025)
4,572
(453)
(9,699,447)
(2,834,356)
(12,533,803)
2025-03-312024-04-01falsefalseCCH SoftwareCCH Accounts Production 2025.100Mr M AireyMrs PM AireyMr C AireyMrs JR Aireyfalse04677336bus:Consolidated2024-04-012025-03-31046773362024-04-012025-03-31046773362025-03-3104677336bus:Consolidated2025-03-3104677336bus:Director12024-04-012025-03-3104677336bus:Director22024-04-012025-03-3104677336bus:Director32024-04-012025-03-3104677336bus:Director42024-04-012025-03-3104677336bus:RegisteredOffice2024-04-012025-03-3104677336bus:Consolidated2023-04-012024-03-31046773362023-04-012024-03-3104677336bus:Consolidated2024-03-31046773362024-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-03-3104677336core:LeaseholdImprovementsbus:Consolidated2025-03-3104677336core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2025-03-3104677336core:FurnitureFittingsbus:Consolidated2025-03-3104677336core:MotorVehiclesbus:Consolidated2025-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-03-3104677336core:LeaseholdImprovementsbus:Consolidated2024-03-3104677336core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2024-03-3104677336core:FurnitureFittingsbus:Consolidated2024-03-3104677336core:MotorVehiclesbus:Consolidated2024-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssets2025-03-3104677336core:LeaseholdImprovements2025-03-3104677336core:ConstructionInProgressAssetsUnderConstruction2025-03-3104677336core:FurnitureFittings2025-03-3104677336core:MotorVehicles2025-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3104677336core:LeaseholdImprovements2024-03-3104677336core:ConstructionInProgressAssetsUnderConstruction2024-03-3104677336core:FurnitureFittings2024-03-3104677336core:MotorVehicles2024-03-3104677336core:ShareCapitalbus:Consolidated2025-03-3104677336core:ShareCapitalbus:Consolidated2024-03-3104677336core:ShareCapital2025-03-3104677336core:ShareCapital2024-03-3104677336core:SharePremiumbus:Consolidated2025-03-3104677336core:SharePremiumbus:Consolidated2024-03-3104677336core:SharePremium2025-03-3104677336core:SharePremium2024-03-3104677336core:CapitalRedemptionReservebus:Consolidated2025-03-3104677336core:CapitalRedemptionReservebus:Consolidated2024-03-3104677336core:CapitalRedemptionReserve2025-03-3104677336core:CapitalRedemptionReserve2024-03-3104677336core:RetainedEarningsAccumulatedLossesbus:Consolidated2025-03-3104677336core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-03-3104677336core:RetainedEarningsAccumulatedLosses2025-03-3104677336core:RetainedEarningsAccumulatedLosses2024-03-3104677336core:ShareCapitalbus:Consolidated2023-03-3104677336core:SharePremiumbus:Consolidated2023-03-3104677336core:CapitalRedemptionReservebus:Consolidated2023-03-31046773362023-03-3104677336core:ShareCapital2023-03-3104677336core:SharePremium2023-03-3104677336core:RetainedEarningsAccumulatedLosses2023-03-3104677336bus:Consolidated2023-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-012025-03-3104677336core:LeaseholdImprovements2024-04-012025-03-3104677336core:FurnitureFittings2024-04-012025-03-3104677336core:MotorVehicles2024-04-012025-03-3104677336core:UKTaxbus:Consolidated2024-04-012025-03-3104677336core:UKTaxbus:Consolidated2023-04-012024-03-3104677336bus:Consolidated12024-04-012025-03-3104677336bus:Consolidated12023-04-012024-03-3104677336bus:Consolidated22024-04-012025-03-3104677336bus:Consolidated22023-04-012024-03-3104677336bus:Consolidated32024-04-012025-03-3104677336bus:Consolidated32023-04-012024-03-3104677336bus:Consolidated42024-04-012025-03-3104677336bus:Consolidated42023-04-012024-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-03-3104677336core:LeaseholdImprovementsbus:Consolidated2024-03-3104677336core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2024-03-3104677336core:FurnitureFittingsbus:Consolidated2024-03-3104677336core:MotorVehiclesbus:Consolidated2024-03-3104677336bus:Consolidated2024-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3104677336core:LeaseholdImprovements2024-03-3104677336core:ConstructionInProgressAssetsUnderConstruction2024-03-3104677336core:FurnitureFittings2024-03-3104677336core:MotorVehicles2024-03-31046773362024-03-3104677336core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-04-012025-03-3104677336core:LeaseholdImprovementsbus:Consolidated2024-04-012025-03-3104677336core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2024-04-012025-03-3104677336core:FurnitureFittingsbus:Consolidated2024-04-012025-03-3104677336core:MotorVehiclesbus:Consolidated2024-04-012025-03-3104677336core:ConstructionInProgressAssetsUnderConstruction2024-04-012025-03-3104677336core:CurrentFinancialInstruments2025-03-3104677336core:CurrentFinancialInstruments2024-03-3104677336core:Non-currentFinancialInstrumentsbus:Consolidated2025-03-3104677336core:Non-currentFinancialInstrumentsbus:Consolidated2024-03-3104677336core:Non-currentFinancialInstruments2025-03-3104677336core:Non-currentFinancialInstruments2024-03-3104677336core:CurrentFinancialInstrumentsbus:Consolidated2025-03-3104677336core:CurrentFinancialInstrumentsbus:Consolidated2024-03-3104677336core:WithinOneYearbus:Consolidated2025-03-3104677336core:WithinOneYearbus:Consolidated2024-03-3104677336core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3104677336core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3104677336core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2025-03-3104677336core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-03-3104677336core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-3104677336core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3104677336core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2025-03-3104677336core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-03-3104677336bus:PrivateLimitedCompanyLtd2024-04-012025-03-3104677336bus:FRS1022024-04-012025-03-3104677336bus:Audited2024-04-012025-03-3104677336bus:ConsolidatedGroupCompanyAccounts2024-04-012025-03-3104677336bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP